Vyome Holdings, Inc. (NASDAQ:HIND) Short Interest Update

Vyome Holdings, Inc. (NASDAQ:HIND) saw a significant decline in short interest during the month of May. As of May 29th, there was short interest totaling 77,671 shares, a decline of 36.9% from the May 14th total of 123,132 shares. Approximately 1.7% of the company’s shares are short sold. Based on an average trading volume of 25,890 shares, the days-to-cover ratio is currently 3.0 days.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Litchfield Hills Research assumed coverage on Vyome in a research report on Monday, May 4th. They set a “buy” rating for the company. Zacks Research raised shares of Vyome to a “hold” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings raised shares of Vyome from a “sell (e)” rating to a “sell (e+)” rating in a report on Friday, May 1st. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Vyome has an average rating of “Hold” and an average price target of $15.00.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Vyome stock. Geode Capital Management LLC acquired a new position in shares of Vyome Holdings, Inc. (NASDAQ:HIND) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 11,934 shares of the company’s stock, valued at approximately $41,000. Geode Capital Management LLC owned about 0.21% of Vyome at the end of the most recent reporting period. Institutional investors own 22.06% of the company’s stock.

Vyome Stock Performance

HIND traded up $0.06 during trading on Wednesday, reaching $2.26. 19,324 shares of the company’s stock were exchanged, compared to its average volume of 475,029. The company’s fifty day moving average price is $2.17 and its 200-day moving average price is $2.81. Vyome has a fifty-two week low of $1.75 and a fifty-two week high of $18.60. The firm has a market capitalization of $15.89 million, a PE ratio of -0.18 and a beta of 1.48.

Vyome (NASDAQ:HIND) last released its earnings results on Tuesday, May 12th. The company reported ($0.15) EPS for the quarter. Vyome had a negative return on equity of 203.92% and a negative net margin of 270.58%.The business had revenue of $0.03 million for the quarter. Research analysts forecast that Vyome will post -0.6 earnings per share for the current fiscal year.

About Vyome

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.